Evidence map›Paper›PMID 38544037›Full record

ArticleSensors (Basel, Switzerland)2024

Open Meter Duo: Low-Cost Instrument for Fluorimetric Determination of Cholinesterase Activity.

Ondřej Keresteš, Juan Daniel Mozo, Miroslav Pohanka

Open access · goldAbstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Ondřej KerestešMilitary Faculty of Medicine, University of Defence, CZ-50001 Hradec Kralove, Czech Republic.ORCID 0000-0003-2369-6357
Juan Daniel MozoFaculty of Experimental Sciences, University of Huelva, 21071 Huelva, Spain.ORCID 0000-0001-6605-2223
Miroslav PohankaMilitary Faculty of Medicine, University of Defence, CZ-50001 Hradec Kralove, Czech Republic.ORCID 0000-0001-8804-8356
University of Defence · CZUniversidad de Huelva · ES

Funding

Ministry of Defence DZRO-FVZ22-ZHN IIMinistry of Education Youth and Sports SV/FVZ202103
6 · The paper itself

Abstract

Environmental screening is essential due to the increased occurrence of harmful substances in the environment. Open Meter Duo (OMD) is an open-source field photo/fluorimeter that uses an RGB diode that imitates a color according to the selected wavelength and uses a UV LED from the security kit diode as an excitation light source. The prepared PCB shield with a 3D-printed aperture was connected to Arduino UNO R4 WiFi. This system was used for the fluorescent detection of cholinesterase activity with the indoxyl acetate method. Carbofuran-a toxic pesticide-and donepezil-a drug used to treat Alzheimer's disease-were tested as model inhibitors of cholinesterase activity. The limit of detection of indoxyl acetate was 11.6 μmol/L, and the IC50 values of the inhibitors were evaluated. This system is optimized for wireless use in field analysis with added cloud support and power source. The time of analysis was 5 min for the fluorimetric assay and 20 min for the optional photometric assay. The time of field operation was approximately 4 h of continuous measurement. This system is ready to be used as a cheap and easy control platform for portable use in drug control and point-of-care testing.

Indexed as

Alzheimer DiseaseCholinesterase InhibitorsCholinesterasesDonepezilFluorometryHumansCholinesterase InhibitorsCholinesterasesDonepezil3D printingArduinocholinesterasefluorimetrylow costportableremote sensing

Identifiers

PMID38544037
PMCPMC10975980
OpenAlexW4392649955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.